Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innovative device for surgical wound irrigation: a preclinical testing and pilot clinical validation study.
Hayashi Y, Noda T, Samizo Y, Fujimoto K, Uemoto E, Yamashita K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Kobayashi S, Eguchi H, Doki Y, Nakajima K. Hayashi Y, et al. Among authors: doki y. Minim Invasive Ther Allied Technol. 2024 Feb 18:1-7. doi: 10.1080/13645706.2024.2317196. Online ahead of print. Minim Invasive Ther Allied Technol. 2024. PMID: 38369855
A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT.
Takiguchi S, Yamamoto K, Hirao M, Imamura H, Fujita J, Yano M, Kobayashi K, Kimura Y, Kurokawa Y, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Takiguchi S, et al. Among authors: doki y. Gastric Cancer. 2012 Apr;15(2):198-205. doi: 10.1007/s10120-011-0098-1. Epub 2011 Oct 13. Gastric Cancer. 2012. PMID: 21993852 Clinical Trial.
Recurrence patterns after curative gastrectomy for pStage II/III gastric cancer: Exploratory analysis of the randomized controlled JCOG1001 trial.
Toriumi T, Terashima M, Mizusawa J, Sato Y, Kurokawa Y, Takiguchi S, Doki Y, Shinohara H, Teshima S, Yasuda T, Ito S, Yoshikawa T, Sano T, Sasako M. Toriumi T, et al. Among authors: doki y. Eur J Surg Oncol. 2023 Apr;49(4):838-844. doi: 10.1016/j.ejso.2022.11.093. Epub 2022 Nov 16. Eur J Surg Oncol. 2023. PMID: 36424261 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 36611068
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer.
Matsuda C, Kudo T, Morimoto Y, Kagawa Y, Tei M, Ide Y, Miyoshi N, Takahashi H, Uemura M, Takemasa I, Satoh T, Mizushima T, Murata K, Doki Y, Eguchi H; Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MSCSGO). Matsuda C, et al. Among authors: doki y. Ann Gastroenterol Surg. 2022 Jul 15;7(1):81-90. doi: 10.1002/ags3.12600. eCollection 2023 Jan. Ann Gastroenterol Surg. 2022. PMID: 36643362 Free PMC article.
Neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy as an independent prognostic factor in patients with esophageal squamous cell carcinoma.
Yamada M, Tanaka K, Yamasaki M, Yamashita K, Makino T, Saito T, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Eguchi H, Doki Y. Yamada M, et al. Among authors: doki y. Oncol Lett. 2022 Dec 20;25(2):58. doi: 10.3892/ol.2022.13644. eCollection 2023 Feb. Oncol Lett. 2022. PMID: 36644140 Free PMC article.
1,582 results